Isomorphic Labs announces Series B investment round
HIGHLIGHTS
- •Isomorphic Labs announced a Series B investment round
- •The company, with a heritage from DeepMind and contributors to the AlphaFold system, is developing a unified drug design engine that operates across multiple therapeutic areas and drug modalities.
- •Aiming to transform drug discovery with AI technology.
Published:
Official Source (Official Website)